2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
19
Completed
18
Recruiting
9
Not yet recruiting
6
Terminated
3
Withdrawn
2
Active not recruiting
2
Enrolling by invitation
1
Sponsor Class
OTHER
3
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Gastrointestinal
3
Conditions
Rectal Neoplasms
1
Esophageal Cancer Surgery
1
Colorectal Neoplasms
1
Interventions
Cyclophosphamide
390
Carboplatin
344
Gemcitabine
332
pembrolizumab
329
Cisplatin
328
Paclitaxel
297
Radiotherapy
296
Docetaxel
286
Bevacizumab
253
Rituximab
234
Capecitabine
223
Nivolumab
220
Dexamethasone
206
Fluorouracil
190
fludarabine
177
Oxaliplatin
177
Pemetrexed
153
Doxorubicin
153
Irinotecan
148
Leucovorin
144
Etoposide
144
Cytarabine
133
Cetuximab
129
Bortezomib
129
fludarabine phosphate
128
Lenalidomide
126
Erlotinib Hydrochloride
120
Filgrastim
119
Temozolomide
113
Radiosurgery
113
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Terminated
×
Preoperative Exercise
×
Clear all
NCT03876561
2026-04-20
CONTICARE
Nantes University Hospital
Phase NA
Terminated
120 enrolled
NCT03798951
2024-01-22
PRESS
Università Vita-Salute San Raffaele
Phase NA
Terminated
21 enrolled
NCT04097795
2023-12-18
PreColo CU
Radboud University Medical Center
Terminated
72 enrolled